Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
3,468,418
-
Share change
-
+41,600
-
Total reported value
-
$534,289,452
-
Price per share
-
$153.99
-
Number of holders
-
247
-
Value change
-
+$6,575,921
-
Number of buys
-
83
-
Number of sells
-
112
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q2 2024
As of 30 Jun 2024,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,468,418 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, Royal Bank of Canada, Berger Financial Group, Inc, Raymond James Financial Services Advisors, Inc., RAYMOND JAMES & ASSOCIATES, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
247
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.